ICON public limited company (ICON) is a contract research organization (CRO) providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. The Company specializes in the strategic development, management and analysis of programs, which support all stages of the clinical development process, which include from compound selection to Phase I-IV clinical studies. In May 2014, the Company acquired Aptiv Solutions.